JoVE Journal
Medicine
Medicine
A subscription to JoVE is required to view this content.
Chapters
Summary
Receptor tyrosine kinases are ectopically expressed in many cancers and have been identified as therapeutic targets in acute leukemia. This manuscript describes an efficient strategy for pre-clinical evaluation of tyrosine kinase inhibitors for the treatment of acute leukemia.